TABLE 8. Incidence rates* and percentages† of invasive pancreatic cancer, by demographic and tumor characteristics — United States,§ 2010–2014.
| Demographic characteristic | Total |
Male |
Female |
|||
|---|---|---|---|---|---|---|
| No. | Rate (95% CI) | No. | Rate (95% CI) | No. | Rate (95% CI) | |
|
Total
|
218,919
|
12.5 (12.4–12.6)
|
111,730
|
14.2 (14.1–14.3)
|
107,189
|
11.0 (11.0–11.1)
|
|
Age group at diagnosis (yrs)
| ||||||
| <40 |
2,502 |
0.3 (0.3–0.3) |
1,182 |
0.3 (0.3–0.3) |
1,320 |
0.3 (0.3–0.4) |
| 40–49 |
9,445 |
4.3 (4.2–4.4) |
5,345 |
5.0 (4.8–5.1) |
4,100 |
3.7 (3.6–3.8) |
| 50–59 |
34,179 |
15.6 (15.4–15.7) |
19,892 |
18.6 (18.3–18.8) |
14,287 |
12.7 (12.5–12.9) |
| 60–69 |
59,397 |
38.2 (37.9–38.6) |
33,373 |
45.2 (44.7–45.7) |
26,024 |
32.0 (31.6–32.4) |
| 70–79 |
59,506 |
68.4 (67.8–68.9) |
30,244 |
77.3 (76.4–78.1) |
29,262 |
61.1 (60.4–61.8) |
| ≥80 |
53,890 |
93.1 (92.3–93.9) |
21,694 |
101.5 (100.2–102.9) |
32,196 |
87.9 (86.9–88.9) |
|
Race
| ||||||
| White |
182,531 |
12.3 (12.2–12.3) |
94,557 |
14.1 (14.0–14.2) |
87,974 |
10.7 (10.6–10.8) |
| Black |
27,174 |
15.5 (15.3–15.7) |
12,671 |
16.9 (16.6–17.2) |
14,503 |
14.4 (14.2–14.6) |
| American Indian/Alaska Native |
1,131 |
8.2 (7.7–8.7) |
587 |
9.1 (8.3–10.0) |
544 |
7.4 (6.7–8.0) |
| Asian/Pacific Islander |
6,787 |
9.3 (9.1–9.5) |
3,227 |
10.0 (9.6–10.4) |
3,560 |
8.7 (8.4–9.0) |
|
Ethnicity¶
| ||||||
| Hispanic |
16,048 |
11.1 (10.9–11.3) |
7,854 |
12.0 (11.7–12.3) |
8,194 |
10.3 (10.1–10.6) |
| Non-Hispanic |
202,859 |
12.6 (12.6–12.7) |
103,870 |
14.5 (14.4–14.5) |
98,989 |
11.1 (11.0–11.2) |
|
County classification
| ||||||
| Metropolitan |
178,483 |
12.6 (12.5–12.7) |
90,388 |
14.3 (14.2–14.4) |
88,095 |
11.2 (11.1–11.2) |
| Nonmetropolitan |
30,997 |
12.1 (12.0–12.3) |
16,246 |
13.9 (13.6–14.1) |
14,751 |
10.6 (10.4–10.8) |
|
Census region
| ||||||
| Northeast |
45,414 |
13.5 (13.4–13.6) |
22,564 |
15.4 (15.2–15.6) |
22,850 |
12.0 (11.8–12.1) |
| Midwest |
49,381 |
12.6 (12.5–12.7) |
25,272 |
14.4 (14.3–14.6) |
24,109 |
11.1 (11.0–11.2) |
| South |
80,688 |
12.4 (12.3–12.4) |
41,527 |
14.1 (14.0–14.3) |
39,161 |
10.9 (10.7–11.0) |
| West |
43,436 |
11.7 (11.6–11.8) |
22,367 |
13.2 (13.0–13.4) |
21,069 |
10.4 (10.3–10.6) |
|
Tumor characteristic**
|
No.
|
%
|
No.
|
%
|
No.
|
%
|
|
Total
|
179,360
|
100.0
|
93,822
|
100.0
|
85,538
|
100.0
|
|
Histology
| ||||||
| Mucinous adenocarcinoma |
5,874 |
3.3 |
2,943 |
3.1 |
2,931 |
3.4 |
| Other adenocarcinomas |
142,872 |
79.7 |
74,884 |
79.8 |
67,988 |
79.5 |
| Epithelial carcinoma, NOS |
8,105 |
4.5 |
4,427 |
4.7 |
3,678 |
4.3 |
| Ductal carcinoma |
17,655 |
9.8 |
8,999 |
9.6 |
8,656 |
10.1 |
| All other histologies |
4,854 |
2.7 |
2,569 |
2.7 |
2,285 |
2.7 |
|
Stage††
| ||||||
| Localized |
18,904 |
10.5 |
9,114 |
9.7 |
9,790 |
11.4 |
| Regional |
60,545 |
33.8 |
30,867 |
32.9 |
29,678 |
34.7 |
| Distant |
92,435 |
51.5 |
50,179 |
53.5 |
42,256 |
49.4 |
| Unknown | 7,476 | 4.2 | 3,662 | 3.9 | 3,814 | 4.5 |
Abbreviations: CI = confidence interval; NOS = not otherwise specified.
* New cases diagnosed per 100,000 persons, age adjusted to the 2000 U.S. standard population.
† New cases diagnosed.
§ Cancer incidence data were compiled from cancer registries that met the data quality criteria for all invasive cancer sites combined, representing approximately 99% of the U.S. population. (Data from Nevada did not meet U.S. Cancer Statistics publication criteria for 2010–2014.)
¶ Ethnicity is not mutually exclusive from race.
** Only includes microscopically confirmed cases; excludes cases identified only through death certificate or autopsy report.
†† Localized: cancer that is confined to the primary site; regional: cancer that has spread directly beyond the primary site or to regional lymph nodes; distant: cancer that has spread to other organs.